Skip to main content
Fig. 1 | Annals of Clinical Microbiology and Antimicrobials

Fig. 1

From: Intestinal carriage of vancomycin‐resistant Enterococcus spp. among high‐risk patients in university hospitals in Serbia: first surveillance report

Fig. 1

Dendogram of Vancomycin-resistant Enterococcus faecium isolates using Unweighted pair group clustering method. VNTR, variable-number tandem-repeat; MT-MLVA type; HO, Haematology-Oncology; Ger, Geriatrics; ICU, Intensive Care Units; AID, Acute Infection Diseases; HD, Haemodyalisis; AMP, Ampicillin; IMP, Imipenem; CIP, Ciprofloxacin; LEV, Levofloxacin; GEN-HLS, Gentamicin-high level aminoglycoside resistance; STR-HLS, Streperomicin-high level aminoglycoside resistance; VAN, Vancomycin; TEI, Teicoplanin; Q–D, Quinupristin–dalfopristin; ddlE. faecium, d-alanine–d-alanine ligase gene specific for E. faecium; ddlE. faecalis, d-alanine–d-alanine ligase gene specific for E. faecalis; van A, type A vancomycin resistance; vanB, type B vancomycin resistance; vanC (C1and C2/3)—type C vancomycin resistance; vat(D) and vat(E), streptogramin A resistance; vgb(A) and ermB-1, streptogramin B resistance; esp, Enterococcal surface protein; hyl, hyaluronidase; efaA, cell wall adhesine; asa1, aggregation substance; gelE, gelatinase; cpd, sex pheromones; N, no virulence genes; +, weak biofilm producer; ++, moderate biofilm producer; +++, strong biofilm producer;–, no biofilm production

Back to article page